Table 1. Association between BE503655 expression and clinicopathological characteristics in 61 osteosarcoma patients.
| Variable | LncRNA BE503655 expression | χ2 | P-value | |
|---|---|---|---|---|
| Low expression (n=27) | High expression (n=34) | |||
| Age (years) | 0.041 | 0.839 | ||
| <18 | 12 | 16 | ||
| ≥18 | 15 | 18 | ||
| Gender | 0.394 | 0.530 | ||
| Male | 18 | 20 | ||
| Female | 9 | 14 | ||
| Enneking stage | 5.522 | 0.019 | ||
| I–IIA | 20 | 15 | ||
| IIB–III | 7 | 19 | ||
| Size (8 cm) | 0.339 | 0.560 | ||
| <8 | 23 | 27 | ||
| ≥8 | 4 | 7 | ||
| Distant metastasis | 6.231 | 0.013 | ||
| Absent | 19 | 13 | ||
| Present | 8 | 21 | ||
| Histological grade | 4.475 | 0.034 | ||
| G1–G2 | 22 | 19 | ||
| G3–G4 | 5 | 15 | ||
Significant difference between the two groups was considered as P<0.05 and is indicated in bold.